Article
The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease using network pharmacology and molecular docking
2021-07-26
Abstract excerpt
<h4>Background: </h4> Interstitial lung disease(ILD) is associated with substantial morbidity and mortality, which is one of key systematic manifestations of connective tissue disease (CTD). Tripterygium wilfordii, known as Leigongteng in Chinese, has been applied to treat connective tissue disease-related interstitial lung disease (CTD-ILD) for many years. Methods Triptolide is key effective components from Tript...
Topics
Open a Topic to create a Post that cites this publication.
- Autophagy in Disease and Therapy
- Cardiovascular Function and Risk Factors
- Cytokine Signaling Pathways and Interactions
- Inflammatory Bowel Disease
- Natural Compounds in Disease Treatment
- Peroxisome Proliferator-Activated Receptors
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Identifiers and source
- Literature Corpus work
- 3a2aa015-9a4a-52c6-b6d9-e1cc126b1bd3
- DOI
- 10.21203/rs.3.rs-744924/v1
